Among the four completed trials, two (LEADER and SUSTAIN-6) demonstrated significant risk reduction in MACE [2, 3], and one (EXSCEL) demonstrated a numerically reduced risk of MACE [28]
Besides, Ex-4 has been shown to exhibit significant antitumor activity, with its usage being strongly associated with a reduced risk of prostate cancer [17]
This page is informational only, is not medical advice, and does not guarantee any specific outcome
Prior Presentation: Findings from this Delphi panel were presented at the World Congress of Nephrology 2026 (2831 March), Yokohama, Japan, poster number P362 (Handelsman et al
Nonetheless, healthcare providers at JosephCareRX may, after careful consideration and thorough evaluation of your individual medical history and needs, prescribe Ozempic off-label for weight reduction purposes, particularly if Wegovy is unavailable or not covered by insurance
Content is provided to you AS IS for your information and personal use only